Literature DB >> 9065652

Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma.

L Smid1, P Strojan, M Budihna, J Skrk, I Vrhovec, M Zargi, J Kos.   

Abstract

Concentrations of cathepsins A, D and stefins A and B were measured in primary tumor and adjacent normal tissue of 25 patients with laryngeal carcinoma. Median concentrations of both cathepsins and that of stefin B were significantly higher in tumor tissue than in their normal counterparts (cathepsins B and D, P < 0.0001; stefin B, P = 0.01), indicating their possible involvement in the process of tumor spread. Early (T1 and T2) tumors had lower concentrations of stefins A and B than locally advanced (T3 and T4) tumors (P = 0.04). Disease-free and disease-specific survival rates at 45 months were significantly better in patients with tumor concentrations of stefins above or equal to the cut-off values (stefin A, P = 0.001 and P = 0.004; stefin B, P = 0.048 and P = 0.008), indicating that these might be of prognostic value. The concentrations of cathepsins B and D did not correlate with survival.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065652     DOI: 10.1007/bf02439748

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  7 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

3.  Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma.

Authors:  T T Lah; J L Clifford; K M Helmer; N A Day; K Moin; K V Honn; J D Crissman; B F Sloane
Journal:  Biochim Biophys Acta       Date:  1989-10-13

4.  Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer.

Authors:  J Kos; A Smid; M Krasovec; B Svetic; B Lenarcic; I Vrhovec; J Skrk; V Turk
Journal:  Biol Chem Hoppe Seyler       Date:  1995-07

5.  Expression of cathepsin D in malignant and in the corresponding non-malignant node-negative laryngeal samples: correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone.

Authors:  S Marsigliante; L Resta; G Leo; D Mazzotta; R d'Amore; L Biscozzo; C Storelli
Journal:  Cancer Lett       Date:  1993-02       Impact factor: 8.679

6.  Expression of cathepsin D in head and neck cancer.

Authors:  R Zeillinger; H Swoboda; E Machacek; D Nekahm; G Sliutz; W Knogler; P Speiser; E Swoboda; E Kubista
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

7.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  7 in total
  6 in total

1.  Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.

Authors:  T Leinonen; R Pirinen; J Böhm; R Johansson; A Rinne; E Weber; V-M Kosma
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Plasma Cystatin B Association With Abdominal Aortic Aneurysms and Need for Later Surgical Repair: A Sub-study of the VIVA Trial.

Authors:  Yunzhe Wang; Cong-Lin Liu; Jes S Lindholt; Guo-Ping Shi; Jinying Zhang
Journal:  Eur J Vasc Endovasc Surg       Date:  2018-09-24       Impact factor: 7.069

3.  Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression.

Authors:  Adam S Feldman; Jacqueline Banyard; Chin-Lee Wu; W Scott McDougal; Bruce R Zetter
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

4.  Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement.

Authors:  Mustafa Paksoy; Umit Hardal; Cakır Caglar
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-26       Impact factor: 4.553

5.  Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.

Authors:  Xingxing Wang; Lu Gui; Youyuan Zhang; Jihong Zhang; Jimin Shi; Guoxiong Xu
Journal:  Int J Oncol       Date:  2014-01-21       Impact factor: 5.650

6.  Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer.

Authors:  Wan-Li Liu; Dan Liu; Kai Cheng; Yi-Jun Liu; Shan Xing; Pei-Dong Chi; Xiao-Hua Liu; Ning Xue; Yan-Zhen Lai; Ling Guo; Ge Zhang
Journal:  Oncotarget       Date:  2016-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.